Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVAX |
---|---|---|
09:32 ET | 26639 | 4.39 |
09:34 ET | 21026 | 4.4451 |
09:36 ET | 25871 | 4.4685 |
09:38 ET | 10960 | 4.475 |
09:39 ET | 38045 | 4.46 |
09:41 ET | 29239 | 4.4501 |
09:43 ET | 14371 | 4.435 |
09:45 ET | 6794 | 4.4579 |
09:48 ET | 12455 | 4.44 |
09:50 ET | 6564 | 4.455 |
09:52 ET | 6144 | 4.46 |
09:54 ET | 2813 | 4.4499 |
09:56 ET | 14061 | 4.44 |
09:57 ET | 11157 | 4.43 |
09:59 ET | 4680 | 4.43 |
10:01 ET | 29113 | 4.406 |
10:03 ET | 1041 | 4.405 |
10:06 ET | 46566 | 4.3999 |
10:08 ET | 13905 | 4.42 |
10:10 ET | 7658 | 4.4101 |
10:12 ET | 10443 | 4.415 |
10:14 ET | 4621 | 4.4217 |
10:15 ET | 6090 | 4.4293 |
10:17 ET | 7102 | 4.445 |
10:19 ET | 6316 | 4.4401 |
10:21 ET | 9514 | 4.4399 |
10:24 ET | 8312 | 4.425 |
10:26 ET | 21600 | 4.4591 |
10:28 ET | 31742 | 4.46 |
10:30 ET | 3257 | 4.46 |
10:32 ET | 13791 | 4.4682 |
10:33 ET | 10300 | 4.45 |
10:35 ET | 2665 | 4.4591 |
10:37 ET | 400 | 4.455 |
10:39 ET | 11020 | 4.451 |
10:42 ET | 6565 | 4.43 |
10:44 ET | 5014 | 4.44 |
10:46 ET | 415 | 4.455 |
10:48 ET | 3628 | 4.4712 |
10:50 ET | 7871 | 4.455 |
10:51 ET | 3983 | 4.46 |
10:53 ET | 5197 | 4.445 |
10:55 ET | 1400 | 4.44 |
10:57 ET | 1224 | 4.445 |
11:00 ET | 22432 | 4.43 |
11:02 ET | 4621 | 4.43 |
11:04 ET | 3660 | 4.445 |
11:06 ET | 813 | 4.445 |
11:08 ET | 5639 | 4.445 |
11:09 ET | 4326 | 4.435 |
11:11 ET | 3653 | 4.43 |
11:13 ET | 4148 | 4.45 |
11:15 ET | 5904 | 4.44 |
11:18 ET | 3662 | 4.45 |
11:20 ET | 4465 | 4.442 |
11:22 ET | 3448 | 4.45 |
11:24 ET | 5275 | 4.46 |
11:26 ET | 8193 | 4.47 |
11:27 ET | 4024 | 4.47 |
11:29 ET | 9667 | 4.46 |
11:31 ET | 6269 | 4.4501 |
11:33 ET | 821 | 4.455 |
11:36 ET | 4445 | 4.455 |
11:38 ET | 1408 | 4.455 |
11:40 ET | 540 | 4.4509 |
11:42 ET | 1808 | 4.455 |
11:44 ET | 1300 | 4.45 |
11:45 ET | 5854 | 4.45 |
11:47 ET | 6790 | 4.445 |
11:49 ET | 17809 | 4.425 |
11:51 ET | 23566 | 4.415 |
11:54 ET | 2510 | 4.41 |
11:56 ET | 688 | 4.4189 |
11:58 ET | 1409 | 4.415 |
12:00 ET | 5500 | 4.42 |
12:02 ET | 100 | 4.41 |
12:03 ET | 820 | 4.42 |
12:05 ET | 6183 | 4.425 |
12:07 ET | 1626 | 4.425 |
12:09 ET | 400 | 4.4203 |
12:12 ET | 2841 | 4.435 |
12:14 ET | 388 | 4.425 |
12:16 ET | 469 | 4.42 |
12:18 ET | 17707 | 4.4 |
12:20 ET | 500 | 4.4 |
12:21 ET | 513 | 4.403 |
12:23 ET | 2500 | 4.4 |
12:25 ET | 23117 | 4.425 |
12:27 ET | 3800 | 4.415 |
12:30 ET | 100 | 4.415 |
12:32 ET | 1019 | 4.4198 |
12:34 ET | 7769 | 4.42 |
12:36 ET | 6089 | 4.43 |
12:38 ET | 1790 | 4.42 |
12:39 ET | 6283 | 4.41 |
12:41 ET | 3576 | 4.415 |
12:43 ET | 3756 | 4.42 |
12:45 ET | 1825 | 4.415 |
12:48 ET | 950 | 4.4199 |
12:50 ET | 5292 | 4.42 |
12:52 ET | 5475 | 4.41 |
12:54 ET | 3344 | 4.415 |
12:56 ET | 10189 | 4.42 |
12:57 ET | 3598 | 4.43 |
12:59 ET | 5599 | 4.43 |
01:01 ET | 800 | 4.43 |
01:03 ET | 1388 | 4.425 |
01:06 ET | 100 | 4.425 |
01:08 ET | 5692 | 4.43 |
01:10 ET | 1108 | 4.42 |
01:12 ET | 1400 | 4.425 |
01:14 ET | 1500 | 4.42 |
01:15 ET | 8333 | 4.425 |
01:17 ET | 600 | 4.43 |
01:19 ET | 4586 | 4.43 |
01:21 ET | 27630 | 4.44 |
01:24 ET | 4318 | 4.4473 |
01:26 ET | 3300 | 4.45 |
01:28 ET | 3610 | 4.45 |
01:30 ET | 4111 | 4.45 |
01:32 ET | 6035 | 4.455 |
01:33 ET | 8550 | 4.45 |
01:35 ET | 2760 | 4.46 |
01:37 ET | 1364 | 4.4567 |
01:39 ET | 1578 | 4.455 |
01:42 ET | 746 | 4.455 |
01:44 ET | 44694 | 4.47 |
01:46 ET | 14472 | 4.46 |
01:48 ET | 16945 | 4.455 |
01:50 ET | 973 | 4.455 |
01:51 ET | 6083 | 4.465 |
01:53 ET | 1734 | 4.47 |
01:55 ET | 2952 | 4.465 |
01:57 ET | 4251 | 4.465 |
02:00 ET | 898 | 4.46 |
02:02 ET | 13127 | 4.46 |
02:04 ET | 9888 | 4.475 |
02:06 ET | 73282 | 4.485 |
02:08 ET | 70054 | 4.5198 |
02:09 ET | 55959 | 4.5209 |
02:11 ET | 36735 | 4.51 |
02:13 ET | 14866 | 4.5285 |
02:15 ET | 6571 | 4.52 |
02:18 ET | 2379 | 4.515 |
02:20 ET | 950 | 4.5101 |
02:22 ET | 9148 | 4.525 |
02:24 ET | 42165 | 4.5494 |
02:26 ET | 60433 | 4.55 |
02:27 ET | 19010 | 4.5689 |
02:29 ET | 35769 | 4.58 |
02:31 ET | 32845 | 4.565 |
02:33 ET | 28956 | 4.575 |
02:36 ET | 73589 | 4.555 |
02:38 ET | 12411 | 4.58 |
02:40 ET | 55407 | 4.64 |
02:42 ET | 77913 | 4.6643 |
02:44 ET | 17274 | 4.67 |
02:45 ET | 34980 | 4.67 |
02:47 ET | 32415 | 4.6959 |
02:49 ET | 80033 | 4.685 |
02:51 ET | 25160 | 4.7199 |
02:54 ET | 15391 | 4.72 |
02:56 ET | 47023 | 4.725 |
02:58 ET | 60828 | 4.73 |
03:00 ET | 38822 | 4.735 |
03:02 ET | 83785 | 4.765 |
03:03 ET | 54282 | 4.74 |
03:05 ET | 34161 | 4.76 |
03:07 ET | 25646 | 4.78 |
03:09 ET | 34587 | 4.8 |
03:12 ET | 71948 | 4.7701 |
03:14 ET | 29336 | 4.77 |
03:16 ET | 31195 | 4.725 |
03:18 ET | 21813 | 4.69 |
03:20 ET | 46497 | 4.6912 |
03:21 ET | 38831 | 4.68 |
03:23 ET | 33062 | 4.7 |
03:25 ET | 43768 | 4.7 |
03:27 ET | 51111 | 4.69 |
03:30 ET | 20414 | 4.69 |
03:32 ET | 46386 | 4.695 |
03:34 ET | 18016 | 4.7099 |
03:36 ET | 28181 | 4.705 |
03:38 ET | 19808 | 4.69 |
03:39 ET | 86159 | 4.685 |
03:41 ET | 83407 | 4.6899 |
03:43 ET | 78934 | 4.685 |
03:45 ET | 28830 | 4.6999 |
03:48 ET | 76848 | 4.6783 |
03:50 ET | 53652 | 4.69 |
03:52 ET | 102959 | 4.67 |
03:54 ET | 57578 | 4.665 |
03:56 ET | 138631 | 4.675 |
03:57 ET | 114821 | 4.68 |
03:59 ET | 229247 | 4.67 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novavax Inc | 606.0M | -0.8x | --- |
P3 Health Partners Inc | 169.7M | -0.9x | --- |
PTC Therapeutics Inc | 2.5B | -4.4x | --- |
Inotiv Inc | 99.0M | -3.0x | --- |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
Invitae Corp | 286.5K | 0.0x | --- |
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $653.6M |
---|---|
Revenue (TTM) | $983.7M |
Shares Outstanding | 140.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-5.53 |
Book Value | $-5.14 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.